The molecular evaluation of thioredoxin (TXN1 & TXN2), thioredoxin reductase 1 (TXNRd1), and oxidative stress markers in a binary rat model of hypo- and hyperthyroidism after treatment with gallic acid
Oxidative stress plays an important role in the pathology of thyroid disorders. This study examined the effect of gallic acid (GA) on the oxidative status and expression of liver antioxidant genes including thioredoxin (TXN1 & TXN2) and thioredoxin reductase1 (TXNRd1) in hypo- and hyperthyroid rat models. Forty-nine male Wistar rats were randomly assigned into seven groups as follows: control group, hypothyroid and hyperthyroid groups respectively induced by propylthiouracil and levothyroxine, hypo- and hyper thyroid-treated groups (where the groups were separately treated with 50 and 100 mg/kg of GA daily, orally). The levels of thyroid hormones and serum oxidative stress markers were evaluated after 5 weeks. The relative expression of TXN1,2 and TXNRd1 genes was measured via real-time qRT-PCR. The mean level of total antioxidant capacity (TAC), malondialdehyde, and uric acid index diminished in the hypothyroid group. Increased TAC reached almost the level of control in hypothyroid groups treated with GA. Elevation of thiol index in the hypothyroid group was observed (p < 0.01), which diminished to the control level after GA treatment. The relative expression of TXN1, TXNRd1, and TXN2 genes in the hypothyroid and hyperthyroid groups significantly increased compared to the control group (p ≥ 0.05), but in the groups treated with GA, the expression of these genes declined significantly (p ≥ 0.05). Our results indicated GA can affect the expression of TXN system genes in the rat liver. Also, the results suggest GA has a more positive effect on modulating serum oxidative parameters in hypothyroid rat models than in hyperthyroid.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:46 |
---|---|
Enthalten in: |
Drug and chemical toxicology - 46(2023), 6 vom: 09. Nov., Seite 1108-1115 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Najafi, Zohreh [VerfasserIn] |
---|
Links: |
---|
Themen: |
52500-60-4 |
---|
Anmerkungen: |
Date Completed 05.09.2023 Date Revised 05.09.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1080/01480545.2022.2131812 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM348283563 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM348283563 | ||
003 | DE-627 | ||
005 | 20231226035816.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1080/01480545.2022.2131812 |2 doi | |
028 | 5 | 2 | |a pubmed24n1160.xml |
035 | |a (DE-627)NLM348283563 | ||
035 | |a (NLM)36314079 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Najafi, Zohreh |e verfasserin |4 aut | |
245 | 1 | 4 | |a The molecular evaluation of thioredoxin (TXN1 & TXN2), thioredoxin reductase 1 (TXNRd1), and oxidative stress markers in a binary rat model of hypo- and hyperthyroidism after treatment with gallic acid |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 05.09.2023 | ||
500 | |a Date Revised 05.09.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Oxidative stress plays an important role in the pathology of thyroid disorders. This study examined the effect of gallic acid (GA) on the oxidative status and expression of liver antioxidant genes including thioredoxin (TXN1 & TXN2) and thioredoxin reductase1 (TXNRd1) in hypo- and hyperthyroid rat models. Forty-nine male Wistar rats were randomly assigned into seven groups as follows: control group, hypothyroid and hyperthyroid groups respectively induced by propylthiouracil and levothyroxine, hypo- and hyper thyroid-treated groups (where the groups were separately treated with 50 and 100 mg/kg of GA daily, orally). The levels of thyroid hormones and serum oxidative stress markers were evaluated after 5 weeks. The relative expression of TXN1,2 and TXNRd1 genes was measured via real-time qRT-PCR. The mean level of total antioxidant capacity (TAC), malondialdehyde, and uric acid index diminished in the hypothyroid group. Increased TAC reached almost the level of control in hypothyroid groups treated with GA. Elevation of thiol index in the hypothyroid group was observed (p < 0.01), which diminished to the control level after GA treatment. The relative expression of TXN1, TXNRd1, and TXN2 genes in the hypothyroid and hyperthyroid groups significantly increased compared to the control group (p ≥ 0.05), but in the groups treated with GA, the expression of these genes declined significantly (p ≥ 0.05). Our results indicated GA can affect the expression of TXN system genes in the rat liver. Also, the results suggest GA has a more positive effect on modulating serum oxidative parameters in hypothyroid rat models than in hyperthyroid | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Gallic acid | |
650 | 4 | |a hyperthyroidism | |
650 | 4 | |a hypothyroidism | |
650 | 4 | |a oxidative stress | |
650 | 4 | |a thioredoxin | |
650 | 7 | |a Thioredoxin Reductase 1 |2 NLM | |
650 | 7 | |a EC 1.8.1.9 |2 NLM | |
650 | 7 | |a Antioxidants |2 NLM | |
650 | 7 | |a Gallic Acid |2 NLM | |
650 | 7 | |a 632XD903SP |2 NLM | |
650 | 7 | |a Immunologic Factors |2 NLM | |
650 | 7 | |a Thioredoxins |2 NLM | |
650 | 7 | |a 52500-60-4 |2 NLM | |
700 | 1 | |a Chamani, Elham |e verfasserin |4 aut | |
700 | 1 | |a Zarban, Asghar |e verfasserin |4 aut | |
700 | 1 | |a Rezaei, Zohreh |e verfasserin |4 aut | |
700 | 1 | |a Sharifzadeh, Gholamreza |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Drug and chemical toxicology |d 1984 |g 46(2023), 6 vom: 09. Nov., Seite 1108-1115 |w (DE-627)NLM000913685 |x 1525-6014 |7 nnns |
773 | 1 | 8 | |g volume:46 |g year:2023 |g number:6 |g day:09 |g month:11 |g pages:1108-1115 |
856 | 4 | 0 | |u http://dx.doi.org/10.1080/01480545.2022.2131812 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 46 |j 2023 |e 6 |b 09 |c 11 |h 1108-1115 |